Rated 2.9 / 5 (How Ratings Work)
Possible to probable range of efficacy of cannabis for treatment of addiction to opiod based pain killers.
Based on 28 Studies from 1976 - 2018
Study Name, Description & Year
Rating
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity And Improved Executive Function After 3 Months Of Treatment
MMJ patients completed the Multi-Source Interference Test while undergoing functional magnetic resonance imaging (fMRI). — 2018
Epidemiological Characteristics, Safety And Efficacy Of Medical Cannabis In The Elderly
A survey conducted on 2736 patients above 65  years who began cannabis treatment. — 2018
Impact Of Co-administration Of Oxycodone And Smoked Cannabis On Analgesia And Abuse Liability
A double-blind, placebo-controlled trial conducted on 18 healthy cannabis smokers. — 2018
Cannabidiol: Swinging The Marijuana Pendulum From 'Weed' To Medication To Treat The Opioid Epidemic
Review — 2017
Cannabis As A Substitute For Opioid-Based Pain Medication: Patient Self-Report
A survey conducted on 2897 medical cannabis patients using opioid-based pain medication in the past 6 month. — 2017
The Endocannabinoid System As A Target For Addiction Treatment: Trials And Tribulations
Review — 2017
Effects Of Cannabidiol On Morphine Conditioned Place Preference In Mice
Animal study (mice) — 2017
Splendor In The Grass? A Pilot Study Assessing The Impact Of Medical Marijuana On Executive Function
A survey of 11 medical cannabis patients — 2016
Early Phase In The Development Of Cannabidiol As A Treatment For Addiction: Opioid Relapse Takes Initial Center Stage
Meta-analysis — 2015
The Dark Side Of Emotion: The Addiction Perspective
Review — 2015
Safety And Pharmacokinetics Of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl In Humans
Double-blind, placebo-controlled cross-over study of CBD, coadministered with intravenous fentanyl — 2015
The Effects Of Dronabinol During Detoxification And The Initiation Of Treatment With Extended Release Naltrexone.
Double-blind, placebo-controlled human study — 2015
Medical Cannabis Laws And Opioid Analgesic Overdose Mortality In The United States, 1999-2010
A time-series analysis was conducted of medical cannabis laws and state-level death certificate data in the United States from 1999 to 2010; all 50 states were included. — 2014
Cannabinoid And Opioid Interactions: Implications For Opiate Dependence And Withdrawal
Review/Meta-Analysis — 2013
Prescribing Cannabis For Harm Reduction
Review study — 2012
Cannabinoid-opioid Interaction In Chronic Pain
Twenty-one individuals with chronic pain, on a regimen of twice-daily doses of sustained-release morphine or oxycodone were enrolled — 2011
Cannabinoid-opioid Interaction In Chronic Pain
Human trial conducted on 21 patients with chronic pain — 2011
Synergy Between Delta9-tetrahydrocannabinol And Morphine In The Arthritic Rat
Animal study (rats) — 2007
Modulation Of Oral Morphine Antinociceptive Tolerance And Naloxone-precipitated Withdrawal Signs By Oral Delta 9-tetrahydrocannabinol
Animal study (mice) — 2003
Attenuation Of Spontaneous Opiate Withdrawal In Mice By The Anandamide Transport Inhibitor AM404
Animal study (mice) — 2002
Reduction Of Opioid Dependence By The CB(1) Antagonist SR141716A In Mice: Evaluation Of The Interest In Pharmacotherapy Of Opioid Addiction.
Animal study (mice) — 2001
Delta9-tetrahydrocannabinol Releases And Facilitates The Effects Of Endogenous Enkephalins: Reduction In Morphine Withdrawal Syndrome Without Change In Rewarding Effect
Animal study (rats) — 2001
Opioid And Cannabinoid Modulation Of Precipitated Withdrawal In Delta(9)-tetrahydrocannabinol And Morphine-dependent Mice
Animal study (mice) — 2001
Endogenous Cannabinoid, 2-arachidonoylglycerol, Attenuates Naloxone-precipitated Withdrawal Signs In Morphine-dependent Mice
Animal study (mice) — 2001
Long-term Treatment With SR141716A, The CB1 Receptor Antagonist, Influences Morphine Withdrawal Syndrome.
Animal study (rats) — 2000
Anandamide Decreases Naloxone-precipitated Withdrawal Signs In Mice Chronically Treated With Morphine
Animal study (mice) — 1995
Correlation Between The In Vivo And An In Vitro Expression Of Opiate Withdrawal Precipitated By Naloxone: Their Antagonism By L-(-)-delta9-tetrahydrocannabinol
Animal Study (Guinea pigs) — 1976